Muntadhar Al Moosawi Gives A Talk on Chromogenic FVIII in Hemophilia A at WHX Labs Dubai
Muntadhar Al Moosawi, Consultant Hematopathology and Head of Transfusion Services and Coagulation Laboratory, shared on LinkedIn:
”Honored to be a speaker at WHX Labs Dubai, where I presented on the clinical utility of the chromogenic Factor VIII assay in hemophilia A.
My talk focused on the well-recognized discrepancies between one-stage clot-based and chromogenic assays—particularly in mild and moderate hemophilia—and the practical implications for accurate diagnosis, monitoring, and therapeutic decision-making in the era of extended half-life products and novel agents.
It was a privilege to engage with colleagues and discuss how optimized assay selection and interpretation can directly impact patient care and laboratory best practices.
Thanks to the Dr. Eiman Alzaabi and Dr. Chethan Belludi for the invitation.”
Stay updated with Hemostasis Today.
-
Oct 20, 2026, 05:02Sanam Loghavi: Test Your Hematology Knowledge at ASH 2026!
-
Oct 20, 2026, 04:13Ifeanyichukwu Ifechidere: DOACs Are Not the Answer to Every Anticoagulation Question
-
Oct 20, 2026, 04:04Sadia Kamal: Honored to Receive the Outstanding Abstract Award at the 20th Midwest Platelet Conference
-
Oct 20, 2026, 04:03Yu-Hsuan Chen: One Antibody, Two Diseases from FcRn Biology to Clinical Translation
-
Oct 20, 2026, 03:49Domenico Simone Castiello: Rethinking Prolonged DAPT in Multivessel PCI – Insights from the DAPT-MVD Trial
-
Oct 20, 2026, 03:37Rucha Patil: Scaling POC Diagnostics for Haemophilia A and VWD Across India
-
Oct 20, 2026, 03:31Zena Vexler: Targeting Neutrophil Elastase and NETosis to Mitigate Infection-Triggered Childhood Stroke
-
Oct 20, 2026, 03:24Chaza Alaji: Diagnosing Protein C and Protein S Deficiency
-
Oct 20, 2026, 03:24Mou Nandi: How Maternal Health During Pregnancy May Shape Infant Development